
Avero Diagnostics added the Roche Elecsys anti-SARS-CoV-2 antibody test to its COVID-19 testing portfolio. The serological test is available now and complements Avero's existing COVID-19 molecular testing program.
The Roche Elecsys test uses a blood sample to provide qualitative detection of high-affinity antibodies to SARS-CoV-2, identifying those with adaptive immune responses to the virus.